Global Metagenomics in Healthcare Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Metagenomics in Healthcare Market Overview

• 1.1 Product Overview and Scope of Metagenomics in Healthcare
• 1.2 Classification of Metagenomics in Healthcare by Types
  • 1.2.1 Global Metagenomics in Healthcare Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Metagenomics in Healthcare Revenue Market Share by Types in 2018
  • 1.2.3 Sample Extraction Kits
  • 1.2.4 Metagenomics Kits
• 1.3 Global Metagenomics in Healthcare Market by Application
  • 1.3.1 Global Metagenomics in Healthcare Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Pharmaceutical Industries
  • 1.3.3 Biotechnology Companies
  • 1.3.4 Pathology Laboratories
  • 1.3.5 Academic and Research Laboratories
  • 1.3.6 Others
• 1.4 Global Metagenomics in Healthcare Market by Regions
  • 1.4.1 Global Metagenomics in Healthcare Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Metagenomics in Healthcare Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Metagenomics in Healthcare Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metagenomics in Healthcare Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Metagenomics in Healthcare Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metagenomics in Healthcare Status and Prospect (2014-2024)
• 1.5 Global Market Size of Metagenomics in Healthcare (2014-2024)

2 Manufacturers Profiles

• 2.1 Illumina
  • 2.1.1 Business Overview
  • 2.1.2 Metagenomics in Healthcare Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Illumina Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 QIAGEN
  • 2.2.1 Business Overview
  • 2.2.2 Metagenomics in Healthcare Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 QIAGEN Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 PerkinElmer
  • 2.3.1 Business Overview
  • 2.3.2 Metagenomics in Healthcare Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 PerkinElmer Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Thermo Fisher Scientific
  • 2.4.1 Business Overview
  • 2.4.2 Metagenomics in Healthcare Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Oxford Nanopore Technologies
  • 2.5.1 Business Overview
  • 2.5.2 Metagenomics in Healthcare Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2018)

3 Global Metagenomics in Healthcare Market Competition, by Players

• 3.1 Global Metagenomics in Healthcare Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Metagenomics in Healthcare Players Market Share
  • 3.2.2 Top 10 Metagenomics in Healthcare Players Market Share
• 3.3 Market Competition Trend

4 Global Metagenomics in Healthcare Market Size by Regions

• 4.1 Global Metagenomics in Healthcare Revenue and Market Share by Regions
• 4.2 North America Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 4.3 Europe Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 4.5 South America Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

5 North America Metagenomics in Healthcare Revenue by Countries

• 5.1 North America Metagenomics in Healthcare Revenue by Countries (2014-2019)
• 5.2 USA Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 5.3 Canada Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

6 Europe Metagenomics in Healthcare Revenue by Countries

• 6.1 Europe Metagenomics in Healthcare Revenue by Countries (2014-2019)
• 6.2 Germany Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 6.3 UK Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 6.4 France Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 6.5 Russia Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 6.6 Italy Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Metagenomics in Healthcare Revenue by Countries

• 7.1 Asia-Pacific Metagenomics in Healthcare Revenue by Countries (2014-2019)
• 7.2 China Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 7.3 Japan Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 7.4 Korea Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 7.5 India Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

8 South America Metagenomics in Healthcare Revenue by Countries

• 8.1 South America Metagenomics in Healthcare Revenue by Countries (2014-2019)
• 8.2 Brazil Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Metagenomics in Healthcare by Countries

• 9.1 Middle East and Africa Metagenomics in Healthcare Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 9.3 UAE Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Metagenomics in Healthcare Revenue and Growth Rate (2014-2019)

10 Global Metagenomics in Healthcare Market Segment by Type

• 10.1 Global Metagenomics in Healthcare Revenue and Market Share by Type (2014-2019)
• 10.2 Global Metagenomics in Healthcare Market Forecast by Type (2019-2024)
• 10.3 Sample Extraction Kits Revenue Growth Rate (2014-2024)
• 10.4 Metagenomics Kits Revenue Growth Rate (2014-2024)

11 Global Metagenomics in Healthcare Market Segment by Application

• 11.1 Global Metagenomics in Healthcare Revenue Market Share by Application (2014-2019)
• 11.2 Metagenomics in Healthcare Market Forecast by Application (2019-2024)
• 11.3 Pharmaceutical Industries Revenue Growth (2014-2019)
• 11.4 Biotechnology Companies Revenue Growth (2014-2019)
• 11.5 Pathology Laboratories Revenue Growth (2014-2019)
• 11.6 Academic and Research Laboratories Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Metagenomics in Healthcare Market Size Forecast (2019-2024)

• 12.1 Global Metagenomics in Healthcare Market Size Forecast (2019-2024)
• 12.2 Global Metagenomics in Healthcare Market Forecast by Regions (2019-2024)
• 12.3 North America Metagenomics in Healthcare Revenue Market Forecast (2019-2024)
• 12.4 Europe Metagenomics in Healthcare Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Metagenomics in Healthcare Revenue Market Forecast (2019-2024)
• 12.6 South America Metagenomics in Healthcare Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Metagenomics in Healthcare Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology